Taiwan ADNI (TW-ADNI) is working to acquire data comparable to that gathered through other WW-ADNI centers; to develop biomarkers of Alzheimer's disease; and to establish and validate MRI and PET images, cerebral spinal fluid measures and blood biomarkers as predictors of the disease. Data collected throughout this study are available to the research community. 

More information about Taiwan ADNI.